Skip to main content
Top
Published in: Respiratory Research 1/2020

Open Access 01-12-2020 | Pulmonary Hypertension | Letter to the Editor

Airway nitrite is increased in extremely preterm infants with bronchopulmonary dysplasia

Authors: Samuel J. Gentle, Amelia Freeman, Rakesh P. Patel, Namasivayam Ambalavanan, Charitharth V. Lal

Published in: Respiratory Research | Issue 1/2020

Login to get access

Abstract

Rationale

Bronchopulmonary dysplasia (BPD) is the most common complication of prematurity and significantly contributes to mortality and morbidity with few predictive biomarkers. Given that nitrites have been implicated in pathways associated with lung disease, we hypothesized that nitrite levels would be altered in the airways of premature infants diagnosed with BPD.

Methods

This was a prospective cohort study of extremely low birth infants (< 28 weeks’ gestation) at the University of Alabama at Birmingham. Nitrite levels from tracheal aspirates (TAs) were compared between intubated and ventilated infants with BPD and gestation matched full term (FT) controls. TA derived nitrite levels from day one after birth were also compared between preterm infants who did and did not develop BPD.

Results

Infants with BPD were found to have significantly elevated nitrite levels in their tracheal aspirates compared to gestation matched FT controls (p < 0.05). There was a trend for increased nitrite levels on postnatal day one in infants that developed BPD compared to infants that did not develop BPD (p = 0.05).

Conclusions

In conclusion, nitrite levels are significantly increased in airways of infants with BPD. Data from a larger cohort are needed to further support the utility of nitrite for BPD prediction.

Trial registration

Not applicable.
Literature
1.
go back to reference Young SL, Evans K, Eu JP. Nitric oxide modulates branching morphogenesis in fetal rat lung explants. Am J Physiol Lung Cell Mol Physiol. 2002;282:L379–85.CrossRef Young SL, Evans K, Eu JP. Nitric oxide modulates branching morphogenesis in fetal rat lung explants. Am J Physiol Lung Cell Mol Physiol. 2002;282:L379–85.CrossRef
2.
go back to reference Balasubramaniam V, Tang JR, Maxey A, Plopper CG, Abman SH. Mild hypoxia impairs alveolarization in the endothelial nitric oxide synthase-deficient mouse. Am J Physiol Lung Cell Mol Physiol. 2003;284:L964–71.CrossRef Balasubramaniam V, Tang JR, Maxey A, Plopper CG, Abman SH. Mild hypoxia impairs alveolarization in the endothelial nitric oxide synthase-deficient mouse. Am J Physiol Lung Cell Mol Physiol. 2003;284:L964–71.CrossRef
3.
go back to reference Jones JA, Ninnis JR, Hopper AO, et al. Nitrite and nitrate concentrations and metabolism in breast milk, infant formula, and parenteral nutrition. JPEN J Parenter Enteral Nutr. 2014;38:856–66.CrossRef Jones JA, Ninnis JR, Hopper AO, et al. Nitrite and nitrate concentrations and metabolism in breast milk, infant formula, and parenteral nutrition. JPEN J Parenter Enteral Nutr. 2014;38:856–66.CrossRef
4.
go back to reference Tejero J, Shiva S, Gladwin MT. Sources of vascular nitric oxide and reactive oxygen species and their regulation. Physiol Rev. 2019;99:311–79.CrossRef Tejero J, Shiva S, Gladwin MT. Sources of vascular nitric oxide and reactive oxygen species and their regulation. Physiol Rev. 2019;99:311–79.CrossRef
5.
go back to reference Pankey EA, Badejo AM, Casey DB, et al. Effect of chronic sodium nitrite therapy on monocrotaline-induced pulmonary hypertension. Nitric Oxide. 2012;27:1–8.CrossRef Pankey EA, Badejo AM, Casey DB, et al. Effect of chronic sodium nitrite therapy on monocrotaline-induced pulmonary hypertension. Nitric Oxide. 2012;27:1–8.CrossRef
6.
go back to reference Kinsella JP, Ivy DD, Abman SH. Inhaled nitric oxide improves gas exchange and lowers pulmonary vascular resistance in severe experimental hyaline membrane disease. Pediatr Res. 1994;36:402–8.CrossRef Kinsella JP, Ivy DD, Abman SH. Inhaled nitric oxide improves gas exchange and lowers pulmonary vascular resistance in severe experimental hyaline membrane disease. Pediatr Res. 1994;36:402–8.CrossRef
7.
go back to reference Barrington KJ, Finer N, Pennaforte T. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev. 2017;1:CD000509.PubMed Barrington KJ, Finer N, Pennaforte T. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev. 2017;1:CD000509.PubMed
8.
go back to reference Walsh MC, Yao Q, Gettner P, et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics. 2004;114:1305–11.CrossRef Walsh MC, Yao Q, Gettner P, et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics. 2004;114:1305–11.CrossRef
9.
go back to reference Lal CV, Travers C, Aghai ZH, et al. The airway microbiome at birth. Sci Rep. 2016;6:31023.CrossRef Lal CV, Travers C, Aghai ZH, et al. The airway microbiome at birth. Sci Rep. 2016;6:31023.CrossRef
10.
go back to reference Lang JD Jr, Teng X, Chumley P, et al. Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J Clin Invest. 2007;117:2583–91.CrossRef Lang JD Jr, Teng X, Chumley P, et al. Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J Clin Invest. 2007;117:2583–91.CrossRef
11.
go back to reference Koch CD, Gladwin MT, Freeman BA, Lundberg JO, Weitzberg E, Morris A. Enterosalivary nitrate metabolism and the microbiome: intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health. Free Radic Biol Med. 2017;105:48–67.CrossRef Koch CD, Gladwin MT, Freeman BA, Lundberg JO, Weitzberg E, Morris A. Enterosalivary nitrate metabolism and the microbiome: intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health. Free Radic Biol Med. 2017;105:48–67.CrossRef
12.
go back to reference Kaneko FT, Arroliga AC, Dweik RA, et al. Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension. Am J Respir Crit Care Med. 1998;158:917–23.CrossRef Kaneko FT, Arroliga AC, Dweik RA, et al. Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension. Am J Respir Crit Care Med. 1998;158:917–23.CrossRef
13.
go back to reference Banks BA, Ischiropoulos H, McClelland M, Ballard PL, Ballard RA. Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia. Pediatrics. 1998;101:870–4.CrossRef Banks BA, Ischiropoulos H, McClelland M, Ballard PL, Ballard RA. Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia. Pediatrics. 1998;101:870–4.CrossRef
14.
go back to reference Yen E, Weinberger BI, Laumbach RJ, et al. Exhaled breath condensate nitrite in premature infants with bronchopulmonary dysplasia. J Neonatal Perinatal Med. 2018;11:399–407.CrossRef Yen E, Weinberger BI, Laumbach RJ, et al. Exhaled breath condensate nitrite in premature infants with bronchopulmonary dysplasia. J Neonatal Perinatal Med. 2018;11:399–407.CrossRef
15.
go back to reference Heckmann M, Kreuder J, Riechers K, et al. Plasma arginine and urinary nitrate and nitrite excretion in bronchopulmonary dysplasia. Biol Neonate. 2004;85:173–8.CrossRef Heckmann M, Kreuder J, Riechers K, et al. Plasma arginine and urinary nitrate and nitrite excretion in bronchopulmonary dysplasia. Biol Neonate. 2004;85:173–8.CrossRef
16.
go back to reference Baliga RS, Milsom AB, Ghosh SM, et al. Dietary nitrate ameliorates pulmonary hypertension: cytoprotective role for endothelial nitric oxide synthase and xanthine oxidoreductase. Circulation. 2012;125:2922–32.CrossRef Baliga RS, Milsom AB, Ghosh SM, et al. Dietary nitrate ameliorates pulmonary hypertension: cytoprotective role for endothelial nitric oxide synthase and xanthine oxidoreductase. Circulation. 2012;125:2922–32.CrossRef
17.
go back to reference Moya MP, Gow AJ, Califf RM, Goldberg RN, Stamler JS. Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newborn. Lancet. 2002;360:141–3.CrossRef Moya MP, Gow AJ, Califf RM, Goldberg RN, Stamler JS. Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newborn. Lancet. 2002;360:141–3.CrossRef
Metadata
Title
Airway nitrite is increased in extremely preterm infants with bronchopulmonary dysplasia
Authors
Samuel J. Gentle
Amelia Freeman
Rakesh P. Patel
Namasivayam Ambalavanan
Charitharth V. Lal
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2020
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-020-01508-8

Other articles of this Issue 1/2020

Respiratory Research 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine